@article{7078692bc4724212ae73de63cb117750,
title = "Letter by Tromp et al Regarding Article, “Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland”",
author = "Tromp, {Tycho R.} and Hovingh, {G. Kees} and Reeskamp, {Laurens F.}",
note = "Funding Information: Dr Hovingh reports research grants from the Netherlands Organization for Scientific Research (vidi 016.156.445), CardioVascular Research Initiative, and European Union. Funding Information: Dr Reeskamp is co-founder of LipidTools B.V. Dr Hovingh reports institutional research support from Aegerion, Amgen, AstraZeneca, Eli Lilly, Genzyme, Ionis, Kowa, Pfizer, Regeneron, Roche, Sanofi, and The Medicines Company; speaker{\textquoteright}s bureau and consulting fees from Amgen, Aegerion, Sanofi, and Regeneron (fees paid to the academic institution); and part-time employment at Novo Nordisk. Dr Tromp reports no conflicts.",
year = "2022",
month = jan,
day = "1",
doi = "https://doi.org/10.1161/ATVBAHA.121.317188",
language = "English",
volume = "42",
pages = "E44--E45",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams & Wilkins",
number = "1",
}